Skip to main content
. 2024 Oct 18;8(7):102596. doi: 10.1016/j.rpth.2024.102596

Table 2.

Laboratory measurements of parameters of the coagulation system. Results are corrected by the Benjamini–Hochberg procedure to control for false discovery rates.

Parameter Total
n= 87
DIC n = 35 No DIC n = 52 P value
D-dimer (μg/L) 4241 (2005-9003) 7927 (4520-13,052) 2339 (1406-4607) <.001
aPTT (s) 43 (36-55) 54 (45-59) 37 (34-44) <.001
PT (%) 67 (52-83) 53 (38-61) 74 (65-91) <.001
INR 1.30 (1.10-1.50) 1.45 (1.30-1.88) 1.20 (1.10-1.30) <.001
Fibrinogen (mg/dL) 570 (419-641) 485 (363-610) 574 (489-672) .066
Platelets (G/L) 103 (51-188) 48 (14-81) 167 (103-258) <.001
Antithrombin (%) 59 (49-71) 52 (42-60) 65 (53-76) .004
EV (nM) 28.34 (14.12-50.14) 29.62 (16.26-49.96) 27.85 (11.78-48.82) .63
TF-PCA (TF eq pg/mL) 0.47 (0.13-1.47) 0.69 (0.25-1.60) 0.28 (0.06-1.42) .12
TF (pg/mL) 100 (73-131) 104 (70-136) 100 (75-123) .69
TFPI (ng/mL) 28.74 (21.63-53.18) 32.58 (25.47-67.48) 25.40 (18.76-45.00) .01
E-selectin (ng/mL) 163.2 (67.9-391.8) 131.8 (49.3-414.7) 177.8 (82.9-370.7) .54

aPTT, activated partial thromboplastin time; DIC, disseminated intravascular coagulopathy; EV, extracellular vesicle; INR, international normalized ratio; PT, prothrombin time; TF, tissue factor; TF-PCA, tissue factor procoagulant activity; TFPI, tissue factor pathway inhibitor.